AAAAAA
Results:
1-21
|
Results: 21
Authors:
URIUDA Y
WANG QD
HATORI N
NORDLANDER R
SJOQUIST PO
MATTSSON C
RYDEN L
Citation: Y. Uriuda et al., CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/, Journal of pharmacological and toxicological methods, 39(2), 1998, pp. 81-89
Authors:
GUSTAFSSON D
ANTONSSON T
BYLUND R
ERIKSSON U
GYZANDER E
NILSSON I
ELG M
MATTSSON C
DEINUM J
PEHRSSON S
KARLSSON O
NILSSON A
SORENSEN H
Citation: D. Gustafsson et al., EFFECTS OF MELAGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR,ON THROMBIN AND FIBRINOLYTIC ENZYMES, Thrombosis and haemostasis, 79(1), 1998, pp. 110-118
Authors:
MEHTA JL
CHEN LY
NICHOLS WW
MATTSSON C
GUSTAFSSON D
SALDEEN TGP
Citation: Jl. Mehta et al., MELAGATRAN, AN ORAL ACTIVE-SITE INHIBITOR OF THROMBIN, PREVENTS OR DELAYS FORMATION OF ELECTRICALLY-INDUCED OCCLUSIVE THROMBUS IN THE CANINE CORONARY-ARTERY, Journal of cardiovascular pharmacology, 31(3), 1998, pp. 345-351
Authors:
MATTSSON C
MAGNUSON K
HELLSTROM S
Citation: C. Mattsson et al., MYRINGOTOMY - A PREREQUISITE FOR THE DEVELOPMENT OF MYRINGOSCLEROSIS, The Laryngoscope, 108(1), 1998, pp. 102-106
Authors:
MATTSSON C
BJORKMAN JA
ULVINGE JC
Citation: C. Mattsson et al., MELAGATRAN, AND HIRUDIN AND HEPARIN AS ADJUNCTS TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A CANINE MODEL OF CORONARY-ARTERY THROMBOLYSIS, Fibrinolysis & proteolysis, 11(3), 1997, pp. 121-128
Authors:
MATTSSON C
HELLSTROM S
Citation: C. Mattsson et S. Hellstrom, INHIBITION OF THE DEVELOPMENT OF MYRINGOSCLEROSIS BY LOCAL-ADMINISTRATION OF FENSPIRIDE, AN ANTIINFLAMMATORY DRUG, European archives of oto-rhino-laryngology, 254(9-10), 1997, pp. 425-429
Authors:
CARLSSON S
NILSSON A
BORJESSON I
HALVARSSON M
ERIKSSON B
MATTSSON C
GUSTAFSSON D
Citation: S. Carlsson et al., MELAGATRAN, A NOVEL LOW-MOLECULAR THROMBIN INHIBITOR EXAMINED IN SEVERAL DEEP VENOUS THROMBOSIS MODELS IN THE RAT, Thrombosis and haemostasis, 1997, pp. 2031-2031
Authors:
GUSTAFSSON D
ANTONSSON T
BYLUND R
ERIKSSON U
GYZANDER E
NILSSON I
ELG M
MATTSSON C
DEINUM J
PERSSON S
KARLSSON O
NILSSON A
SORENSEN H
Citation: D. Gustafsson et al., EFFECTS OF A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, MELAGATRAN,ON THROMBIN AND FIBRINOLYTIC ENZYMES - EVALUATION OF THE SUFFICIENT SELECTIVITY, Thrombosis and haemostasis, 1997, pp. 2032-2032
Authors:
ERIKSSON BI
CARLSSON S
HALVARSSON M
RISBERG B
MATTSSON C
Citation: Bi. Eriksson et al., ANTITHROMBOTIC EFFECT OF 2 LOW-MOLECULAR-WEIGHT THROMBIN INHIBITORS AND A LOW-MOLECULAR-WEIGHT HEPARIN IN A CAVAL VEIN-THROMBOSIS MODEL IN THE RAT, Thrombosis and haemostasis, 78(5), 1997, pp. 1404-1407
Authors:
MATTSSON C
CARLSSON L
MARKLUND SL
HELLSTROM S
Citation: C. Mattsson et al., MYRINGOTOMIZED MICE DEVELOP MYRINGOSCLEROSIS IN THE PARS FLACCIDA ANDNOT IN THE PARS TENSA, The Laryngoscope, 107(2), 1997, pp. 200-205
Authors:
MATTSSON C
MARKLUND SL
HELLSTROM S
Citation: C. Mattsson et al., APPLICATION OF OXYGEN-FREE RADICAL SCAVENGERS TO DIMINISH THE OCCURRENCE OF MYRINGOSCLEROSIS, The Annals of otology, rhinology & laryngology, 106(6), 1997, pp. 513-518
Authors:
MATTSSON C
Citation: C. Mattsson, ICSE-18 - INDUSTRY AND RESEARCH COME TOGETHER - MORE-OR-LESS, IEEE software, 13(5), 1996, pp. 105
Authors:
CARLSSON S
CHEN JS
MATTSSON C
Citation: S. Carlsson et al., HEAPS WITH BITS, Theoretical computer science, 164(1-2), 1996, pp. 1-12
Authors:
CHEN LY
NICHOLS WW
MATTSSON C
TEGERNILSSON AC
SALDEEN TGP
MEHTA JL
Citation: Ly. Chen et al., INOGATRAN, A NOVEL DIRECT LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, GIVEN WITH, BUT NOT AFTER, TISSUE-PLASMINOGEN ACTIVATOR, IMPROVES THROMBOLYSIS, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1276-1283
Authors:
URIUDA Y
WANG QD
GRIP L
RYDEN L
SJOQUIST PO
MATTSSON C
Citation: Y. Uriuda et al., ANTITHROMBOTIC ACTIVITY OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN, IN A CLOSED-CHEST PORCINE MODEL OF CORONARY-ARTERY THROMBOSIS, Cardiovascular Research, 32(2), 1996, pp. 320-327
Authors:
TEGERNILSSON AC
GYZANDER E
ANDERSSON S
ENGLUND M
MATTSSON C
ULVINGE JC
GUSTAFSSON D
Citation: Ac. Tegernilsson et al., IN-VITRO PROPERTIES OF INOGATRAN, A NEW SELECTIVE LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1325-1325
Authors:
MATTSSON C
TEGERNILSSON AC
SALDEEN TGP
CHEN LY
NICHOLS WW
KHAN S
MEHTA JL
Citation: C. Mattsson et al., THROMBIN INHIBITION CONCOMITANT WITH, BUT NOT AFTER, TISSUE-PLASMINOGEN ACTIVATOR (T-PA) INFUSION REDUCES REOCCLUSION RATES AND INTRACORONARY FIBRIN DEPOSITION, Thrombosis and haemostasis, 73(6), 1995, pp. 1342-1342
Authors:
CHEN LY
NICHOLS WW
MATTSSON C
TEGERNILSON AC
WALLIN R
SALDEEN TGP
MEHTA JL
Citation: Ly. Chen et al., ASPIRIN DOES NOT POTENTIATE EFFECT OF SUBOPTIMAL DOSE OF THE THROMBININHIBITOR INOGATRAN DURING CORONARY THROMBOLYSIS, Cardiovascular Research, 30(6), 1995, pp. 866-874
Authors:
VOLKER W
BOHM A
SCHMIDT A
SVAHN CM
GELLERBRING AK
MATTSSON C
EKVARN S
ROBENEK H
BUDDECKE E
Citation: W. Volker et al., INHIBITION OF SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMAL GROWTH BY LOW-ANTICOAGULANT HEPARIN, Arzneimittel-Forschung, 45(5), 1995, pp. 546-550
Authors:
MATTSSON C
MAGNUSON K
HELLSTROM S
Citation: C. Mattsson et al., MYRINGOSCLEROSIS CAUSED BY INCREASED OXYGEN CONCENTRATION IN TRAUMATIZED TYMPANIC MEMBRANES - EXPERIMENTAL-STUDY, The Annals of otology, rhinology & laryngology, 104(8), 1995, pp. 625-632
Authors:
WIKSTROM K
MATTSSON C
POHL G
Citation: K. Wikstrom et al., A BLEEDING MODEL IN RABBITS DEMONSTRATE FRESH CLOT SELECTIVITY FOR A GENETICALLY ENGINEERED VARIANT OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND FOR STREPTOKINASE, Thrombosis research, 70(3), 1993, pp. 217-224
Risultati:
1-21
|